Post-COVID-19 syndrome management: Utilizing the potential of dietary polysaccharides - 13/09/23


Abstract |
The COVID-19 pandemic has caused significant global impact, resulting in long-term health effects for many individuals. As more patients recover, there is a growing need to identify effective management strategies for ongoing health concerns, such as post-COVID-19 syndrome, characterized by persistent symptoms or complications beyond several weeks or months from the onset of symptoms. In this review, we explore the potential of dietary polysaccharides as a promising approach to managing post-COVID-19 syndrome. We summarize the immunomodulatory, antioxidant, antiviral, and prebiotic activities of dietary polysaccharides for the management of post-COVID-19 syndrome. Furthermore, the review investigates the role of polysaccharides in enhancing immune response, regulating immune function, improving oxidative stress, inhibiting virus binding to ACE2, balancing gut microbiota, and increasing functional metabolites. These properties of dietary polysaccharides may help alleviate COVID-19 symptoms, providing a promising avenue for effective treatment strategies.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
CONCLUSION:Dietary polysaccharides may help alleviate COVID-19symptoms on the persistence of the COVID-19 virus in the human bodyafter recovery, directly and indirectly.
CONCLUSION:Dietary polysaccharides may help alleviate COVID-19symptoms on the persistence of the COVID-19 virus in the human bodyafter recovery, directly and indirectly.ga1Le texte complet de cet article est disponible en PDF.
Highlights |
• | The COVID-19 has caused long-term health effects, including post-COVID-19 syndrome. |
• | The need for effective management strategies for post-COVID-19 syndrome. |
• | Immunomodulatory, antioxidant, and prebiotic activities of dietary polysaccharides. |
• | Polysaccharides can strengthen the immune system and enhance gastrointestinal health. |
• | The potential of dietary polysaccharides in managing post-COVID-19 symptoms. |
Abbreviation : 12,13-DiHOME, ACE2, AMPK, ARE, CAT, CCL, COVID-19, DSS, GPR, GPx, HpODE, Ig, IL, INF, IRAK1, Keap1, MAPK, MDA, MyD88, NF-κB, Nrf2, ROS, SARS-CoV-2, SCFAs, SOD, TLR, TNF-α, TRAF6
Keywords : Post-COVID-19, Polysaccharides, Immunomodulation, Oxidative stress, Antiviral, Gut microbiota
Plan
Vol 166
Article 115320- octobre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.